Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide in Pediatric Pilocytic Astrocytomas and Optic Pathway Gliomas
NCT01553149Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2012
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of lenalidomide in Juvenile Pilocytic Astrocytoma (JPA), optic pathway glioma (OPG), sponsored by National Cancer Institute. Started Jul 2012; status: completed.
02
Drugs
lenalidomide
03
Conditions
Juvenile Pilocytic Astrocytoma (JPA)optic pathway glioma (OPG)
Beyond the preview
Go deeper on NCT01553149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01553149.